Epithalon was first discovered in the 1980s by Dr. Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology during research on natural peptides derived from the pineal gland. Over several decades, animal and human studies have associated Epithalon with extended lifespan, improved immune function, and enhanced antioxidant defense. Clinical trials in Russia have shown potential benefits for age-related disorders, telomere length restoration, and overall well-being. Ongoing global research continues to explore its role in healthy aging and longevity optimization.